Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
46
JKS Quote, Financials, Valuation and Earnings
Last price:
$23.18
Seasonality move
:
19.08%
Day range:
$23.00 - $24.65
52-week range:
$13.42 - $37.36
Dividend yield:
12.03%
P/E ratio:
34.59x
P/S ratio:
0.10x
P/B ratio:
0.47x
Volume:
600K
Avg. volume:
835.6K
1-year change:
0.3%
Market cap:
$1.2B
Revenue:
$12.9B
EPS (TTM):
-$5.04
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.1B | $6.3B | $12.4B | $16.8B | $12.9B | |
| Revenue Growth (YoY) | 18.2% | 24.22% | 95.72% | 35.57% | -23.37% | |
| Cost of Revenues | $4.2B | $5.3B | $10.5B | $14.1B | $11.5B | |
| Gross Profit | $894.3M | $1B | $1.8B | $2.7B | $1.4B | |
| Gross Profit Margin | 17.57% | 16.31% | 14.77% | 16.05% | 10.9% | |
| R&D Expenses | $56.4M | $71.5M | $107.9M | $128.9M | $128.3M | |
| Selling, General & Admin | $562.7M | $746.5M | $1.6B | $1.6B | $1.6B | |
| Other Inc / (Exp) | -$154.4M | -$19.8M | $85.6M | $28.2M | $89.5M | |
| Operating Expenses | $591.3M | $745.9M | $1.5B | $1.6B | $1.4B | |
| Operating Income | $303M | $285.3M | $281.7M | $1.1B | $48.3M | |
| Net Interest Expenses | $66.5M | $96.6M | $73.1M | $87.3M | $101.5M | |
| EBT. Incl. Unusual Items | $82.1M | $168.8M | $294.3M | $1.1B | $36.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $25.9M | $30.1M | $90.1M | $178.2M | $9.7M | |
| Net Income to Company | $48.6M | $148M | $233M | $912.2M | $1.9M | |
| Minority Interest in Earnings | -$15.2M | -$36.3M | -$140.6M | -$424.8M | $5.7M | |
| Net Income to Common Excl Extra Items | $33.4M | $111.7M | $92.4M | $487.4M | $7.6M | |
| Basic EPS (Cont. Ops) | $0.75 | $2.34 | $1.86 | $9.39 | $0.14 | |
| Diluted EPS (Cont. Ops) | $0.75 | $1.25 | $1.85 | $8.61 | -$0.71 | |
| Weighted Average Basic Share | $44.7M | $47.7M | $49.5M | $51.9M | $52.2M | |
| Weighted Average Diluted Share | $44.7M | $51.4M | $50.1M | $56.5M | $52.5M | |
| EBITDA | $380.4M | $577.7M | $865.8M | $2.4B | $1.3B | |
| EBIT | $180M | $298.6M | $455M | $1.2B | $195.5M | |
| Revenue (Reported) | $5.1B | $6.3B | $12.4B | $16.8B | $12.9B | |
| Operating Income (Reported) | $303M | $285.3M | $281.7M | $1.1B | $48.3M | |
| Operating Income (Adjusted) | $180M | $298.6M | $455M | $1.2B | $195.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $2.3B | $3.4B | $3.2B | $1.9B | |
| Revenue Growth (YoY) | 0.71% | 89.8% | 46.74% | -5.51% | -40.91% | |
| Cost of Revenues | $1B | $2B | $2.8B | $2.8B | $2B | |
| Gross Profit | $209.4M | $350.3M | $590.4M | $382.2M | -$48.5M | |
| Gross Profit Margin | 17.11% | 15.08% | 17.32% | 11.87% | -2.55% | |
| R&D Expenses | $16.5M | $22.8M | $27.5M | $33.6M | $20.9M | |
| Selling, General & Admin | $150.8M | $321.1M | $385.8M | $396.1M | $324.5M | |
| Other Inc / (Exp) | $5M | -$2.4M | $15.8M | $240.2M | -$19.8M | |
| Operating Expenses | $147.3M | $295.9M | $374.8M | $397.3M | $271.7M | |
| Operating Income | $62.1M | $54.4M | $215.6M | -$15.1M | -$320.2M | |
| Net Interest Expenses | $24.1M | $25.5M | $8.1M | $26.1M | $32.6M | |
| EBT. Incl. Unusual Items | $42.9M | $26.6M | $223.4M | $199M | -$372.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $8M | $11.2M | $46M | $66.6M | -$96.1M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$7.5M | -$11.9M | -$88.4M | -$49.1M | $101.4M | |
| Net Income to Common Excl Extra Items | $34.1M | $4.6M | $115.2M | $85.2M | -$181.3M | |
| Basic EPS (Cont. Ops) | $0.72 | $0.09 | $2.29 | $1.58 | -$3.52 | |
| Diluted EPS (Cont. Ops) | -$0.55 | $0.09 | $2.19 | $0.75 | -$3.52 | |
| Weighted Average Basic Share | $47.6M | $48.1M | $50.5M | $54M | $51.6M | |
| Weighted Average Diluted Share | $51.3M | $48.1M | $52.7M | $55.9M | $51.6M | |
| EBITDA | $67.1M | $52.1M | $265.8M | $238.4M | -$325.6M | |
| EBIT | $67.1M | $52.1M | $265.8M | $238.4M | -$325.6M | |
| Revenue (Reported) | $1.2B | $2.3B | $3.4B | $3.2B | $1.9B | |
| Operating Income (Reported) | $62.1M | $54.4M | $215.6M | -$15.1M | -$320.2M | |
| Operating Income (Adjusted) | $67.1M | $52.1M | $265.8M | $238.4M | -$325.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.1B | $7.4B | $13.3B | $16.6B | $11.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.2B | $6.3B | $11.3B | $14.1B | $10.6B | |
| Gross Profit | $865.9M | $1.2B | $2B | $2.5B | $971.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $63M | $77.8M | $111.7M | $134.8M | $115.5M | |
| Selling, General & Admin | $592.7M | $918M | $1.7B | $1.6B | $1.5B | |
| Other Inc / (Exp) | -$135.1M | -$27.5M | $97.3M | $254.9M | -$169.6M | |
| Operating Expenses | $608M | $895.8M | $1.6B | $1.6B | $1.2B | |
| Operating Income | $257.9M | $278.2M | $438.1M | $885.2M | -$256.6M | |
| Net Interest Expenses | $75.1M | $98M | $55.9M | $104.9M | $108M | |
| EBT. Incl. Unusual Items | $47.6M | $152.7M | $480M | $1B | -$534.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $17.8M | $33.3M | $123.2M | $198.9M | -$152.7M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$20.7M | -$40.7M | -$214.9M | -$385.9M | $155.9M | |
| Net Income to Common Excl Extra Items | $23.1M | $82.2M | $194.7M | $458.5M | -$258.4M | |
| Basic EPS (Cont. Ops) | $0.49 | $1.73 | $3.96 | $8.85 | -$5.01 | |
| Diluted EPS (Cont. Ops) | -$1.78 | $1.04 | $2.03 | $6.54 | -$5.04 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $181.9M | $284.2M | $653M | $1.2B | -$367.3M | |
| EBIT | $122.8M | $284.2M | $653M | $1.2B | -$367.3M | |
| Revenue (Reported) | $5.1B | $7.4B | $13.3B | $16.6B | $11.5B | |
| Operating Income (Reported) | $257.9M | $278.2M | $438.1M | $885.2M | -$256.6M | |
| Operating Income (Adjusted) | $122.8M | $284.2M | $653M | $1.2B | -$367.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $2.3B | $3.4B | $3.2B | $1.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1B | $2B | $2.8B | $2.8B | $2B | |
| Gross Profit | $209.4M | $350.3M | $590.4M | $382.2M | -$48.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $16.5M | $22.8M | $27.5M | $33.6M | $20.9M | |
| Selling, General & Admin | $150.8M | $321.1M | $385.8M | $396.1M | $324.5M | |
| Other Inc / (Exp) | $5M | -$2.4M | $15.8M | $240.2M | -$19.8M | |
| Operating Expenses | $147.3M | $295.9M | $374.8M | $397.3M | $271.7M | |
| Operating Income | $62.1M | $54.4M | $215.6M | -$15.1M | -$320.2M | |
| Net Interest Expenses | $24.1M | $25.5M | $8.1M | $26.1M | $32.6M | |
| EBT. Incl. Unusual Items | $42.9M | $26.6M | $223.4M | $199M | -$372.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $8M | $11.2M | $46M | $66.6M | -$96.1M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$7.5M | -$11.9M | -$88.4M | -$49.1M | $101.4M | |
| Net Income to Common Excl Extra Items | $34.1M | $4.6M | $115.2M | $85.2M | -$181.3M | |
| Basic EPS (Cont. Ops) | $0.72 | $0.09 | $2.29 | $1.58 | -$3.52 | |
| Diluted EPS (Cont. Ops) | -$0.55 | $0.09 | $2.19 | $0.75 | -$3.52 | |
| Weighted Average Basic Share | $47.6M | $48.1M | $50.5M | $54M | $51.6M | |
| Weighted Average Diluted Share | $51.3M | $48.1M | $52.7M | $55.9M | $51.6M | |
| EBITDA | $67.1M | $52.1M | $265.8M | $238.4M | -$325.6M | |
| EBIT | $67.1M | $52.1M | $265.8M | $238.4M | -$325.6M | |
| Revenue (Reported) | $1.2B | $2.3B | $3.4B | $3.2B | $1.9B | |
| Operating Income (Reported) | $62.1M | $54.4M | $215.6M | -$15.1M | -$320.2M | |
| Operating Income (Adjusted) | $67.1M | $52.1M | $265.8M | $238.4M | -$325.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $1.3B | $1.5B | $2.3B | $3.4B | |
| Short Term Investments | $87.2M | $23.5M | $15.1M | $144.4M | $127.2M | |
| Accounts Receivable, Net | $756.9M | $1.2B | $2.4B | $3.2B | $1.9B | |
| Inventory | $1.3B | $2.1B | $2.5B | $2.6B | $1.7B | |
| Prepaid Expenses | $276.4M | $300.8M | $482.4M | $777.9M | $485.8M | |
| Other Current Assets | $22M | $20.7M | $477M | $16.1M | $13.1M | |
| Total Current Assets | $5.2B | $7.1B | $9.9B | $11.7B | $9.4B | |
| Property Plant And Equipment | $2.3B | $3.6B | $5B | $6.3B | $6.3B | |
| Long-Term Investments | $29.7M | $99.4M | $248M | $313.4M | $276.9M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $122M | $179.7M | $219M | $337.2M | $315.1M | |
| Other Long-Term Assets | $229.1M | $189.5M | $207.4M | $224.5M | $184.3M | |
| Total Assets | $8.1B | $11.5B | $15.7B | $19.2B | $17.1B | |
| Accounts Payable | $681.2M | $1.1B | $1.5B | $2.2B | $1.5B | |
| Accrued Expenses | $227.5M | $292.6M | $426.4M | $522M | $476.5M | |
| Current Portion Of Long-Term Debt | $1.5B | $2.1B | $1.8B | $2B | $732.3M | |
| Current Portion Of Capital Lease Obligations | $49.1M | $40.4M | $33.9M | $88M | $237.5M | |
| Other Current Liabilities | -- | $87.2M | -- | $161.3M | $2.8M | |
| Total Current Liabilities | $4.8B | $7.1B | $9.4B | $11.4B | $7.5B | |
| Long-Term Debt | $1.1B | $1.7B | $2B | $2.2B | $3.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.2B | $9.2B | $11.8B | $14.4B | $12.4B | |
| Common Stock | $4K | $4.1K | $4.1K | $4.1K | $4K | |
| Other Common Equity Adj | $86.2M | -$24.2M | $31.5M | $50.7M | $30.8M | |
| Common Equity | $1.5B | $1.7B | $2.4B | $2.8B | $2.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $459.6M | $507.9M | $1.5B | $1.9B | $2B | |
| Total Equity | $2B | $2.2B | $3.9B | $4.7B | $4.7B | |
| Total Liabilities and Equity | $8.1B | $11.5B | $15.7B | $19.2B | $17.1B | |
| Cash and Short Terms | $1.2B | $1.3B | $1.5B | $2.4B | $3.6B | |
| Total Debt | $4.1B | $5.7B | $6.8B | $7.7B | $5.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $931.5M | $2.4B | $1.3B | $2.5B | $3.8B | |
| Short Term Investments | $109.4M | -- | $22.7M | -- | -- | |
| Accounts Receivable, Net | $743.6M | $1.3B | $2.6B | $2.8B | $1.8B | |
| Inventory | $1.4B | $2.5B | $3.1B | $2.8B | $1.8B | |
| Prepaid Expenses | $213.2M | $486.3M | $612.8M | $640.3M | $262.8M | |
| Other Current Assets | $432.3M | $493.3M | $499.7M | $752.8M | $628.9M | |
| Total Current Assets | $5.2B | $9.8B | $10.2B | $11.6B | $9.3B | |
| Property Plant And Equipment | $2.3B | $3.8B | $5B | $6.2B | $6.1B | |
| Long-Term Investments | $33.2M | $102.4M | $369.2M | $308.3M | $262.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $123.3M | $187.2M | $225.9M | $306.4M | $315.4M | |
| Other Long-Term Assets | $578.7M | $480.4M | $513.9M | $634.7M | $420.2M | |
| Total Assets | $8.3B | $14.5B | $16.5B | $19.3B | $16.8B | |
| Accounts Payable | $698M | $1.1B | $1.8B | $2.1B | $1.6B | |
| Accrued Expenses | $136.9M | $189.9M | $272.7M | $348.2M | $359.2M | |
| Current Portion Of Long-Term Debt | $1.4B | $2.2B | $2B | $1.3B | $1.2B | |
| Current Portion Of Capital Lease Obligations | $42.5M | $41.8M | $30.4M | $20M | $14.2M | |
| Other Current Liabilities | -- | $88.7M | -- | -- | -- | |
| Total Current Liabilities | $4.9B | $8.4B | $9.6B | $11.3B | $7B | |
| Long-Term Debt | $1.1B | $1.9B | $2.3B | $2.3B | $4.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.2B | $10.7B | $12.3B | $14.4B | $12.5B | |
| Common Stock | $4K | $4.3K | $4.1K | -- | -- | |
| Other Common Equity Adj | $102.6M | $87M | $24.6M | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $463.6M | $1.5B | $1.6B | $1.9B | $1.8B | |
| Total Equity | $2.1B | $3.8B | $4.2B | $4.9B | $4.4B | |
| Total Liabilities and Equity | $8.3B | $14.5B | $16.5B | $19.3B | $16.8B | |
| Cash and Short Terms | $1B | $2.4B | $1.3B | $2.5B | $3.8B | |
| Total Debt | $4.2B | $7.1B | $7B | $7.4B | $6.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $48.6M | $148M | $233M | $912.2M | $1.9M | |
| Depreciation & Amoritzation | $200.4M | $279.1M | $410.8M | $1.2B | $1.1B | |
| Stock-Based Compensation | $133.8K | $1.5M | $149M | $122M | $51M | |
| Change in Accounts Receivable | $137.1M | -$604.1M | -$2.1B | -$592.4M | $1.2B | |
| Change in Inventories | -$409M | -$882.6M | -$901.2M | -$542.2M | $333.7M | |
| Cash From Operations | $85.7M | $66.7M | -$863.6M | $2B | $2.3B | |
| Capital Expenditures | $600.8M | $1.3B | $1.8B | $2.2B | $1.3B | |
| Cash Acquisitions | $4.2M | -$48.8M | -$105.2M | $5.1M | $154.4M | |
| Cash From Investing | -$712.7M | -$1.8B | -$1.8B | -$2.1B | -$404.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$79.1M | -$76.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.1B | $5.5B | $4.4B | $3.6B | $4B | |
| Long-Term Debt Repaid | -$3.7B | -$3.8B | -$4.1B | -$3B | -$3.2B | |
| Repurchase of Common Stock | -$4.2M | -- | -- | -$11.2M | -$121.9M | |
| Other Financing Activities | $533M | -- | $1.4B | $19.9M | $498.5M | |
| Cash From Financing | $912.5M | $1.9B | $3B | $1.2B | -$873.6M | |
| Beginning Cash (CF) | $909.1M | $1.3B | $1.4B | $1.6B | $2.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $285.5M | $176.4M | $289.7M | $1B | $1.1B | |
| Ending Cash (CF) | $1.2B | $1.4B | $1.7B | $2.7B | $3.9B | |
| Levered Free Cash Flow | -$515.1M | -$1.3B | -$2.7B | -$286.2M | $1B | |
| Period Ending | 2016-09-30 | 2017-09-30 | 2018-09-30 | 2019-09-30 | 2020-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $148.3M | $17.8M | -- | $75.8M | $100.8M | |
| Depreciation & Amoritzation | $96.2M | $64.6M | -- | $88.8M | $143.2M | |
| Stock-Based Compensation | $8.3M | $6.9M | -- | $1.6M | $125.1K | |
| Change in Accounts Receivable | -$284.7M | -$14.8M | -- | $12.9M | -$87.6M | |
| Change in Inventories | -$48.5M | -$152.7M | -- | -$63.2M | -$297.7M | |
| Cash From Operations | -$51.8M | -$134.6M | -- | $17.6M | -$243.3M | |
| Capital Expenditures | $583.1M | $282.4M | -- | $442.3M | $348.1M | |
| Cash Acquisitions | $10.5M | $214.4K | -- | -$23.8M | $6M | |
| Cash From Investing | -$711.1M | -$383M | -- | -$726M | -$312.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.9B | $2.5B | -- | $2.3B | $2.4B | |
| Long-Term Debt Repaid | -$1.2B | -$2.1B | -- | -$1.7B | -$2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$4.2M | |
| Other Financing Activities | $19.4M | -$4.7M | -- | $231.9M | $123.8M | |
| Cash From Financing | $709.6M | $467.4M | -- | $806.9M | $579.5M | |
| Beginning Cash (CF) | $552.5M | $375.2M | -- | $496.3M | $906.1M | |
| Foreign Exchange Rate Adjustment | $4M | -$7.3M | -- | $3.7M | -$4.9M | |
| Additions / Reductions | -$53.3M | -$50.2M | -- | $98.5M | $23.8M | |
| Ending Cash (CF) | $503.2M | $317.7M | -- | $598.4M | $925M | |
| Levered Free Cash Flow | -$634.9M | -$417M | -- | -$424.7M | -$591.4M | |
| Period Ending | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $12.9M | $6.9M | -- | $1.6M | $125.1K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | $746.3M | $282.4M | -- | $442.3M | $348.1M | |
| Cash Acquisitions | $12.8M | $214.4K | -- | -$23.8M | $6M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$1.2B | -- | -- | -- | -- | |
| Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get JKS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
JKS
Sector
P/E ratio
34.59x
23.84x
PEG ratio
0.02x
0.00x
P/B ratio
0.47x
2.31x
Price / LTM sales
0.10x
1.64x
Growth Metrics
JKS
Sector
Revenue growth
-40.91%
3.84%
Earnings growth
-97.59%
10.8%
Revenue (5-year growth)
24.45%
6.27%
Earnings forecast
-$1.23
$0.12
Profitability
JKS
Sector
Profitability FY 2024
$1.4B
$77.3M
Return on invested capital
-2.27%
0.05%
Return on assets
-1.44%
-0.48%
Return on equity
-5.5%
0.73%
Earnings Date
Last Earnings Date
Apr
29
Next Earnings Date
Aug
29
Estimated Next Earnings Date
Jul
29
Balance Sheet
JKS
Sector
Total cash
$3.8B
$48.7M
Short term investments
$127.2M
$19.4M
Total assets
$17.1B
$223.8M
Long term debt
$6.6B
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
